Tissue-penetrating delivery of compounds and nanoparticles into tumors. - Wikidata - wikimedia - TriplyDB

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

http://www.wikidata.org/entity/Q35016106

about

NRP1 function and targeting in neurovascular development and eye disease Systemically Administered, Target Organ-Specific Therapies for Regenerative Medicine The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics Magnetic particle imaging (MPI) for NMR and MRI researchers Biosafe nanoscale pharmaceutical adjuvant materials αV integrins in angiogenesis and cancer Approaches to improve tumor accumulation and interactions between monoclonal antibodies and immune cells Toward a magic or imaginary bullet? Ligands for drug targeting to cancer cells: principles, hopes, and challenges Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilities Neuropilins and liver Peptides as targeting probes against tumor vasculature for diagnosis and drug delivery Isolation of rare tumor cells from blood cells with buoyant immuno-microbubbles Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma Exploring the tumor microenvironment with nanoparticles Phage display discovery of novel molecular targets in glioblastoma-initiating cells Furin targeted drug delivery for treatment of rhabdomyosarcoma in a mouse model Efficient elimination of cancer cells by deoxyglucose-ABT-263/737 combination therapy Peripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in mice A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1 A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGD Tumor-Specific Peptide, Selected from a Phage Peptide Library, Enhances Antitumor Activity of Lactaptin Replication Study: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs Enhancing Tumor Penetration of Nanomedicines.Ultrasound-guided therapeutic modulation of hepatocellular carcinoma using complementary microRNAs Increasing Tumor Accessibility with Conjugatable Disulfide-Bridged Tumor-Penetrating Peptides for Cancer Diagnosis and Treatment.The use of therapeutic peptides to target and to kill cancer cells.β₁Integrin/FAK/cortactin signaling is essential for human head and neck cancer resistance to radiotherapy Delivery of cancer therapeutics using nanotechnology Quantity and accessibility for specific targeting of receptors in tumours.Selection of phage-displayed peptides on live adherent cells in microfluidic channels.Combinatorial peptide libraries: mining for cell-binding peptides.Novel target for peptide-based imaging and treatment of brain tumors Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells.sTRAIL-iRGD is a promising therapeutic agent for gastric cancer treatment Quantification of confocal images of biofilms grown on irregular surfaces The effect of superparamagnetic iron oxide with iRGD peptide on the labeling of pancreatic cancer cells in vitro: a preliminary study.Targeting of drugs and nanoparticles to tumors.Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy.Antitumor effect of iRGD-modified liposomes containing conjugated linoleic acid-paclitaxel (CLA-PTX) on B16-F10 melanoma.

P2860

Q26765952-EC6B84EB-22C4-4920-88E0-A54F33BF16A8 Q26782082-28B0B3D1-B63E-4D04-9736-49BA244662AE Q26795601-9064FF23-6699-47E1-B2C8-AFEF6AD232BA Q26827983-852E1090-066A-40A9-BB7B-6103835DA10F Q26829798-954CC45D-F468-4054-9436-639ECEDD8C48 Q26851768-68816504-23CC-4776-BB73-FB0D4F378AE2 Q26852287-25A168BF-4085-4F2F-B72B-799783FD7B6F Q26995399-C8F9F10D-AD9D-47AD-8FA0-BE8E91FA5B99 Q27011598-93CD646C-CC0B-42C3-B35F-EC9DAEB95346 Q27024032-4B859B2A-D8F5-45F5-88B2-164DF94F329C Q27024850-59F66956-83CD-461B-8AE3-DB3064D49F48 Q27335994-A4FF4A57-4CDA-4CC8-AEB1-F977BE18FE76 Q28068437-358A7CF8-842A-4923-8A4C-6D8B917AAD58 Q28082374-6A914987-A9E5-4A84-BB45-558E3A45BB1A Q28240138-859928C7-0387-49B4-8E02-3C5320CAE44D Q28473831-28046619-8BE2-4A40-A89C-9307242FF78D Q28477131-294B1EA7-0C26-4E83-8329-2827FD780D15 Q28486624-EDF4C555-E07B-4616-9712-CC02748AA8C3 Q28535426-A56CE1CB-7600-46C2-AC74-8A5468905908 Q28548244-BC8BD27A-5FEB-4236-936E-0C2A3437D6CD Q28553463-4ADA2A61-D710-4D45-A072-594A8115ADE8 Q28559700-88413585-99A3-42A7-9309-06761DB2170E Q28647159-8B0FDB40-D4D3-4053-AA70-BB7728F7D932 Q30356887-747FCBDB-AAC2-4D34-A912-462A483D3C0C Q30367369-E24E173E-4609-491B-9270-620FBDB9761C Q30379645-2BF05BF6-120E-4207-AB0C-2E12C2180E37 Q30418414-FC056F15-B18B-4E10-9954-F7EE57058030 Q30427521-A26CC9EE-45F8-4E80-A653-82F07E93048D Q30446963-D6ED3A63-5BE4-4216-9290-38CDCBEAC797 Q30580276-C1046088-C3D1-41A6-B475-222CDC1DB74B Q31004986-457889EC-B17F-439F-8365-3EBDBA843CDD Q31144876-120ACF71-5582-491B-ABB7-DCF0F2DC1030 Q33554409-C3A53107-E7E1-49EE-AABE-CE5098F31F66 Q33634653-8B0BE52C-92FE-46DA-9F3E-FE02651A21A9 Q33674412-889F2057-5C4B-4543-8084-B8509D8116BC Q33697147-567BC5C6-31AB-4AFC-8FFA-62C22F0DFFA6 Q33746572-71339179-F121-464C-81F6-3DB661904BBC Q33751710-1CA5EFFF-0589-483A-8266-D25F79AD9974 Q33829569-F9C4EB07-0DA5-4E76-AEFF-A8BB6065C86D Q33830347-99975EC9-DE4B-413D-9B91-E767264E2596

P2860

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

http://www.wikidata.org/entity/Q35016106

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

@ast

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

@en

type

label

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

@ast

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

@en

prefLabel

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

@ast

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

@en

P1433

Q35016106-C9BE2BD2-1E2F-4A0C-86C2-6E667FEFD3B9

P1476

Q35016106-1B2B73A6-EB12-4741-8350-B91F46FF7571

P2093

Q35016106-5A520D4F-D4CE-4CD7-8D1F-B596BC100F92

Q35016106-70828FAB-A59E-46FC-A19E-F0ED997AE041

Q35016106-91C1E6B7-0A19-4E1B-9F23-7C035B5C4F00

Q35016106-A5B3C86F-B750-4C61-804F-E56F90366FF0

Q35016106-CDCC792F-7E78-4D01-BD82-FCD10DAFC6F4

Q35016106-DAF5EABB-47DD-4C55-93C6-9D7F90D39EA5

Q35016106-E07BEC49-5486-4931-A63E-0E55C0ABB773

P2860

Q35016106-0686BE41-E75F-4EA6-839E-49F1D6027404

Q35016106-0A2BF88A-88C1-459D-BFCB-201752D065BC

Q35016106-0D687DA5-D689-43E0-A521-1AAACAD50833

Q35016106-12F8C2D4-010C-48AE-B679-7BA7A4C51ABC

Q35016106-2062AAAE-638E-4C12-8950-FF9DB0161851

Q35016106-242833C3-D899-4828-B23A-92C9DF48BDEF

Q35016106-2ABC5CC0-E506-43C8-AD82-E69C92960305

Q35016106-2DEA22E7-22AC-4701-9F35-39FA11E119F7

Q35016106-2EC01319-0A38-46FC-B75D-8168286BE518

Q35016106-30C1C8BB-3A0B-4B48-A1D2-C4634C98C039

P304

Q35016106-C02A3C02-0489-4D1B-9212-4142FFAE76EA

P31

Q35016106-D609A6EC-D359-4319-9FDB-993DAD42567E

P356

Q35016106-882DFE8C-5767-4C9C-9FFE-586C043DDE7F

P433

Q35016106-6E2F1C92-FF48-4B23-8E56-59C0F7DC503F

P478

Q35016106-6F93DD81-613A-4C62-9855-DFD69A1800C7

P50

Q35016106-8451CEB6-9EB4-4821-A74D-E24F400AA8F9

Q35016106-DF09A875-1A07-4086-BACC-38A1A3AE8BD5

P577

Q35016106-EACD45C6-C9BE-44B5-8EF3-1581354FD7E4

P5875

Q35016106-B052079B-D57E-4AEC-BB0B-DF69EEAE978D

P698

Q35016106-4BC678ED-35D3-4621-BD02-087855702513

P921

Q35016106-0357AF91-B377-4051-A214-432B5EA36943

P932

Q35016106-2FFB9EE1-E79E-4002-A061-5BA025222746

P356

J.CCR.2009.10.013

P1433

P1476

Tissue-penetrating delivery of compounds and nanoparticles into tumors.

@en

P2093

Kazuki N Sugahara

http://www.w3.org/2001/XMLSchema#string

Lilach Agemy

http://www.w3.org/2001/XMLSchema#string

Olivier M Girard

http://www.w3.org/2001/XMLSchema#string

Priya Prakash Karmali

http://www.w3.org/2001/XMLSchema#string

Robert F Mattrey

http://www.w3.org/2001/XMLSchema#string

Tambet Teesalu

http://www.w3.org/2001/XMLSchema#string

Venkata Ramana Kotamraju

http://www.w3.org/2001/XMLSchema#string

P2860

Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor

A fragment of the HMGN2 protein homes to the nuclei of tumor cells and tumor endothelial cells in vivo

Matriptase and its putative role in cancer

Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule

High interstitial fluid pressure - an obstacle in cancer therapy

Role of hemagglutinin cleavage for the pathogenicity of influenza virus.

Inhibition of cell surface receptor-bound plasmin by alpha 2-antiplasmin and alpha 2-macroglobulin.

Biomimetic amplification of nanoparticle homing to tumors

In vivo magnetic resonance imaging of acute brain inflammation using microparticles of iron oxide.

An address system in the vasculature of normal tissues and tumors.

P304

510-520

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2009.10.013

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Douglas Hanahan

Erkki Ruoslahti

P577

2009-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40449649

http://www.w3.org/2001/XMLSchema#string

P698

19962669

http://www.w3.org/2001/XMLSchema#string

P921

P932

2791543

http://www.w3.org/2001/XMLSchema#string